ORI Capital
Hong Kong SARori-capital.com
Overview
ORI Capital is a venture capital firm founded in 2015. Our Funds invest in innovative early-stage biotech companies globally, in the areas of diagnostics, drug delivery, and therapeutics focused on the disease areas with the highest mortality rates: cancer, cardiovascular and neurodegenerative diseases .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CG Oncology | Nov 2022 | Series E | Lead |
| AffyImmune Therapeutics | Oct 2021 | Series A | Lead |
| Ponce De Leon Health | Mar 2021 | Series B | Co-investor |
| CG Oncology | Dec 2020 | Series D | Co-investor |
| Pillar Biosciences | May 2020 | Series C | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
